 |
Previous Article | Next Article 
The Journal of Neuroscience, January 15, 2003, 23(2):416-421
The Second Galanin Receptor GalR2 Plays a Key Role in Neurite
Outgrowth from Adult Sensory Neurons
Sally-Ann
Mahoney1,
Richard
Hosking1,
Sarah
Farrant1,
Fiona E.
Holmes1,
Arie S.
Jacoby2,
John
Shine2,
Tiina P.
Iismaa2,
Malcolm K.
Scott3,
Ralf
Schmidt4, and
David
Wynick1
1 University Research Centre for Neuroendocrinology,
Bristol University, Bristol BS2 8HW, United Kingdom, 2 The
Garvan Institute of Medical Research, Sydney, NSW 2010, Australia,
3 Johnson & Johnson Pharmaceutical Research Institute,
Spring House, Pennsylvania 19477-0776, and 4 AstraZeneca
R&D Montreal, Montreal, Quebec H4S 1Z9, Canada
Expression of the neuropeptide galanin is markedly upregulated
within the adult dorsal root ganglion (DRG) after peripheral nerve
injury. We demonstrated previously that the rate of peripheral nerve
regeneration is reduced in galanin knock-out mice, with similar
deficits observed in neurite outgrowth from cultured mutant DRG
neurons. Here, we show that the addition of galanin peptide significantly enhanced neurite outgrowth from wild-type sensory neurons
and fully rescued the observed deficits in mutant cultures. Furthermore, neurite outgrowth in wild-type cultures was reduced to
levels observed in the mutants by the addition of the galanin antagonist M35 [galanin(1-13)bradykinin(2-9)]. Study of the first galanin receptor (GalR1) knock-out animals demonstrated no
differences in neurite outgrowth compared with wild-type animals.
Similarly, use of a GalR1-specific antagonist had no effect on
neuritogenesis. In contrast, use of a GalR2-specific agonist had
equipotent effects on neuritogenesis to galanin peptide, and inhibition
of PKC reduced neurite outgrowth from wild-type sensory neurons to that
observed in galanin knock-out cultures. These results demonstrate that adult sensory neurons are dependent, in part, on galanin for neurite extension and that this crucial physiological process is mediated by
activation of the GalR2 receptor in a PKC-dependent manner.
Key words:
galanin; GalR2; dorsal root ganglion; neuritogenesis; nerve injury; protein kinase C
Copyright © 2003 Society for Neuroscience 0270-6474/03/232416-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Bacon, N. C. H. Kerr, F. E. Holmes, K. Gaston, and D. Wynick
Characterization of an Enhancer Region of the Galanin Gene That Directs Expression to the Dorsal Root Ganglion and Confers Responsiveness to Axotomy
J. Neurosci.,
June 13, 2007;
27(24):
6573 - 6580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Kozoriz, J. B. Kuzmiski, M. Hirasawa, and Q. J. Pittman
Galanin Modulates Neuronal and Synaptic Properties in the Rat Supraoptic Nucleus in a Use and State Dependent Manner
J Neurophysiol,
July 1, 2006;
96(1):
154 - 164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Gottsch, H. Zeng, J. G. Hohmann, D. Weinshenker, D. K Clifton, and R. A. Steiner
Phenotypic Analysis of Mice Deficient in the Type 2 Galanin Receptor (GALR2)
Mol. Cell. Biol.,
June 1, 2005;
25(11):
4804 - 4811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Xia, S. Kjaer, K. Zheng, P.-S. Hu, L. Bai, J.-Y. Jia, R. Rigler, A. Pramanik, T. Xu, T. Hokfelt, et al.
Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: Constitutive and ligand-induced internalization
PNAS,
October 19, 2004;
101(42):
15207 - 15212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Genetically Modified Animals in Endocrinology
Endocr. Rev.,
August 1, 2004;
25(4):
673 - 677.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ahren, G. Pacini, D. Wynick, N. Wierup, and F. Sundler
Loss-of-Function Mutation of the Galanin Gene Is Associated with Perturbed Islet Function in Mice
Endocrinology,
July 1, 2004;
145(7):
3190 - 3196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Elliott-Hunt, B. Marsh, A. Bacon, R. Pope, P. Vanderplank, and D. Wynick
Galanin acts as a neuroprotective factor to the hippocampus
PNAS,
April 6, 2004;
101(14):
5105 - 5110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Counts, S. E. Perez, S. D. Ginsberg, S. de Lacalle, and E. J. Mufson
Galanin in Alzheimer Disease
Mol. Interv.,
May 1, 2003;
3(3):
137 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|